A MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING THE CLINICAL EFFECTS OF MONTELUKAST INTRAVENOUS WITH PLACEBO IN PATIENTS WITH ACUTE ASTHMA
Not Applicable
- Conditions
- -J45J45
- Registration Number
- PER-034-04
- Lead Sponsor
- MERCK & CO.INC.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The patient is a male or female at least 15 years of age.
Not pregnant.
Asthma history of at least 1 year.
During Period I, the patient has a forced expiratory volume in 1 second (FEV1) <50% of the predicted value in all measurements.
Exclusion Criteria
The patient has some known or suspected cause, acute or chronic. for your pulmonary symptoms other than asthma.
Patients with fever.
The patient has received any anti-asthmatic therapy other than oxygen, pagonists, anticholinergics, or corticosteroids.
The patient has some comorbidity alteration different to asthma diagnosed by history, physical examination, or laboratory results.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method